EUROMACS-RHF Score

The EUROMACS‑RHF Score predicts early (<30 days) severe right‑sided heart failure after LVAD implantation 1 [Level I evidence].

RA/PCWP > 0.54
No0Yes+2
Hemoglobin ≤10 g/dL
No0Yes+1
Multiple IV inotropes
No0Yes+2.5
INTERMACS class 1-3
No02+2
Severe RV dysfunction
No0Yes+2

Indications for Use

Used in adults undergoing continuous‑flow LVAD implantation to estimate early (<30‑day) right‑heart failure risk, guide pre‑implant optimization, and anticipate need for inotropes or RVAD support. High scores identify patients with ~43% RHF risk and markedly worse 1‑ and 2‑year survival 1 [Level I evidence]. Supports risk‑based planning, including perioperative RV management and counseling; externally validated to predict severe RHF and ICU stay 2 [Level II evidence].

Insights & Cautions

Predicts early severe RHF after LVAD using 5 pre‑op variables and performs best at low and high scores; intermediate scores are poorly discriminative (external validation n=88; RHF 24%; high‑score PPV 52%, low‑score NPV 52% 1 [Level II evidence]). Developed from a large multicenter cohort (n=2988 2 [Level II evidence]). Underestimates mild RHF and overestimates moderate–severe RHF in off‑pump LVAD cases 3 [Level II evidence]. Use only as adjunct due to modest discrimination.